Conferences AIDS 2016
Other Infections
AIDS 2016: How Can Clinical Services Engage Men Who Have Sex With Men in Africa?
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Men who have sex with men (MSM) living in African countries have an extremely high burden of HIV, Stefan Baral of Johns Hopkins University reminded delegates at the recent 21st International AIDS Conference (AIDS 2016) in Durban. But in situations often marked by widespread social disapproval of homosexual behavior, health services for MSM are few and far between.
AIDS 2016: NYC Clinic Outlines How to Improve PrEP Uptake by Transgender People
- Details
- Category: HIV Prevention
- Published on Tuesday, 20 September 2016 00:00
- Written by Roger Pebody
Dedicated efforts are needed to engage transgender men and women with clinical services and to encourage them to use pre-exposure prophylaxis (PrEP), Asa Radix from the Callen-Lorde Community Health Center in New York said during a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.
AIDS 2016: Neglect of Infectious Disease in Prisons Highlighted at Conference
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Wednesday, 07 September 2016 00:00
- Written by Theo Smart
A special issue of The Lancet was published to coincide with the recent 21st International AIDS Conference in Durban, containing a comprehensive seriesof reviews on the burden of HIV, hepatitis B, hepatitis C, and tuberculosis (TB) among prisoners worldwide.
AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable
- Details
- Category: HIV Prevention
- Published on Thursday, 08 September 2016 00:00
- Written by Roger Pebody
An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer HIV infections, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use, and preferred it to possible alternatives such as tablets or vaginal gels.
AIDS 2016: PrEP Study Achieves High Engagement and Adherence Among Black Gay Men
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 02 September 2016 00:00
- Written by Gus Cairns
What was described at the 21st International AIDS Conference (AIDS 2016) as the first PrEP trial devised and run by black gay men has shown that high levels of pre-exposure prophylaxis (PrEP) use, retention, and adherence can be achieved in a demonstration project if recruitment and support structures are tailored to the needs of black men who have sex with men.
AIDS 2016: Realism Needed About the Benefits and Risks of Taking Part in HIV Cure Research
- Details
- Category: Search for a Cure
- Published on Thursday, 08 September 2016 00:00
- Written by Roger Pebody
A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, according to research presented at the recent 21st International AIDS Conference (AIDS 2016) in Durban. However, some potential participants may not fully understand that taking part in an early-phase study is highly unlikely to afford any personal clinical benefit, but might have the potential to cause harm.
AIDS 2016: Earlier HIV Treatment Is Not Over-burdening Health Services
- Details
- Category: Global Access
- Published on Thursday, 01 September 2016 00:00
- Written by Keith Alcorn
Earlier antiretroviral treatment initiation is not overwhelming rural health services in South Africa, but changes in treatment eligibility criteria alone may not be enough to increase the number of people on treatment substantially, and more investment will be needed in testing and linkage to care to reach treatment coverage goals, research presented at the recent 21st International AIDS Conference (AIDS 2016) shows.
AIDS 2016: HIV Will Only Be Cured with Combined Approaches, Conference Delegates Hear
- Details
- Category: Search for a Cure
- Published on Thursday, 08 September 2016 00:00
- Written by Gus Cairns
Curing people of HIV infection will have to involve combinations of drugs and approaches, just as HIV treatment does, delegates heard at the Towards an HIV Cure workshop held in advance of the recent 21st International AIDS Conference (AIDS 2016) in Durban. The reason is the same, too: HIV can easily develop resistance to single agents, even ones as sophisticated as broadly neutralizing antibodies and gene-editing enzymes.
AIDS 2016: San Francisco Sees Progress in Getting to Zero Initiative
- Details
- Category: HIV Policy & Advocacy
- Published on Thursday, 01 September 2016 00:00
- Written by Liz Highleyman
San Francisco continues to make good progress with its "Getting to Zero" initiative, which aims to achieve the triple goal of zero new HIV infections, zero AIDS deaths, and zero stigma for people living with HIV. But not all groups are doing equally well, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban.
More Articles...
- AIDS 2016: Study Looks at Use of HIV PrEP Before and During Pregnancy and Breastfeeding
- AIDS 2016: New HIV Infections Have Stopped Declining Worldwide, Now Rising in Some Regions
- AIDS 2016: Infection Prophylaxis Reduces Risk of Death for People Starting HIV Treatment Late
- AIDS 2016: Mapping Local HIV Epidemics Can Help Target Resources to Areas with Greatest Need
- AIDS 2016: New WHO Algorithm Aims to Prevent TB Deaths in People with Advanced HIV
- AIDS 2016: High-Dose Rifampicin for TB May Improve Survival of HIV+ People with Low CD4 Counts
- AIDS 2016: Reducing Clinic Visits Supports Retention in HIV Care, African Studies Show
- AIDS 2016: Market Constraints and Uncertainties May Limit Scale-Up of HIV Self-Testing
- AIDS 2016: New Strategy Aims to End AIDS in Children by 2020
- AIDS 2016: Vaginal Bacteria May Increase HIV Susceptibility and Reduce PrEP Effectiveness
- AIDS 2016: No New HIV Infections Seen in San Francisco's Strut PrEP Program
- AIDS 2016: Efavirenz Appears Associated with Elevated Suicide Risk in START Trial
- AIDS 2016: International AIDS Society Releases New HIV Cure Research Strategy
- AIDS 2016: Ongoing Hepatitis B Virus Replication Raises Mortality for People with HIV
- AIDS 2016: Does Detectable CMV Signal High Mortality Risk for Older People with HIV and TB?
- AIDS 2016: Seeking a Cure, Doctors Document Bone Marrow Transplant Recipients with HIV
- AIDS 2016: Access to Home Testing Doubles Frequency of HIV Testing Among Australian Gay Men
- AIDS 2016: HIV Viral Load Pilot Study Shows Roll-Out Will Depend on an Educated Workforce
- AIDS 2016: HIV Criminalization on the Rise, Especially in Sub-Saharan Africa
- AIDS 2016: Training Community Health Workers Leads to Surge in TB Diagnoses in Malawi
- AIDS 2016: AbbVie 3D and 2D Hepatitis C Combos Work Well for HIV/HCV Coinfected People
- Coverage of 21st International AIDS Conference (AIDS 2016)
- AIDS 2016: START Analysis Looks at Who Benefits Most from Immediate HIV Treatment
- AIDS 2016: Starting Treatment on the Day of HIV Diagnosis Improves Outcomes
- AIDS 2016: PrEP Rollout in France Tops 1000, Ipergay Shows 97% Effectiveness
- AIDS 2016: Early HIV Treatment -- Mothers Say They Need Time to Think
- AIDS 2016: HIV Stigma Persists in the Undetectable Era
- AIDS 2016: Once-Daily Raltegravir Works as Well as Twice-Daily For Initial HIV Treatment
- AIDS 2016: Bone Loss Recovers After Stopping PrEP, Biannual Kidney Monitoring Enough for Most
- AIDS 2016: Study Looks at Comprehensive HIV Treatment and Prevention Services for Sex Workers
- AIDS 2016: Large Test-and-Treat Study Fails to Show Impact on New HIV Infections
- AIDS 2016: Progress Towards 90-90-90 Targets in Southern Africa -- Find the Men!
- AIDS 2016: Dolutegravir Plus Lamivudine Works Well as First-Line HIV Treatment
- AIDS 2016: More Confidence on Zero Risk -- Still No Linked HIV Infections in PARTNER Study
- AIDS 2016: New HIV Vaccine Efficacy Trial Set to Start this Year
- AIDS 2016: SEARCH Study Exceeds 90-90-90 Targets After 2 Years of HIV Test-and-Treat
- AIDS 2016: South Africa Has Driven Mother-to-Child HIV Transmission Down to 4%
- AIDS 2016: HIV Treatment Programs Need to Prepare for a "Youth Bulge"
- AIDS 2016: Australia Adopts Ambitious Plan to Use PrEP to "Virtually Eliminate" HIV
- AIDS 2016: Sofosbuvir/ Velpatasvir Shows High Cure Rate in HIV/HCV Coinfection Study
- AIDS 2016: Long-Acting Injectable Drugs Work Well for HIV Maintenance Therapy
- AIDS 2016: Young Gay Men Can Do Well on PrEP, But May Need More Support
- AIDS 2016: PrEP Can Further Reduce HIV Risk After Partner Starts Antiretroviral Treatment
- AIDS 2016: Young Women Treated Very Early Stay HIV Negative and Preserve Immune Function
- AIDS 2016: PrEP Use Exceeds 79,000 in U.S., But Some Groups Lagging Behind
- AIDS 2016: Researchers Now Focusing on Best Ways to Get PrEP to People Who Need It
- AIDS 2016: Progress Towards 90-90-90 Targets is Promising, But Funding Is the Critical Step
- AIDS 2016: TB 2016 Demands a Global Commitment to End Tuberculosis
- AIDS 2016: Shortened Regimen for MDR-TB Shows Good Results for Children
- AIDS 2016: Gains in Curbing HIV Could Be Lost Without Continued Commitment
- AIDS 2016: International AIDS Conference Starts Next Week in Durban
- AIDS 2016: International AIDS Conference Coming Up in Durban
- AIDS 2016: Second Durban Declaration Highlights Key Advances and Barriers
Web Design and Development by